Piqray-Educational material - Guide for healthcare professionals - Management of risk of hyperglycaemia - digital version
The objective of these materials is to raise awareness of the increased risk of hyperglycaemia associated with alpelisib treatment, as well as to provide information concerning:
- signs and symptoms of severe hyperglycaemia (including ketoacidosis)
- monitoring required before and during treatment
- management of hyperglycaemia associated with alpelisib